These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12883468)

  • 41. Therapy insight: heart disease and the insulin-resistant patient.
    Cook SA; Aitman T; Naoumova RP
    Nat Clin Pract Cardiovasc Med; 2005 May; 2(5):252-60. PubMed ID: 16265509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type 2 diabetes mellitus as a conformational disease.
    Hayden MR; Tyagi SC; Kerklo MM; Nicolls MR
    JOP; 2005 Jul; 6(4):287-302. PubMed ID: 16006679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nitric oxide (NO) and vascular oxidative stress. Importance in coronary disease, hypertension, diabetes mellitus and heart failure].
    Weber M; Harrison DG; Kojda G
    Med Monatsschr Pharm; 2000 Jan; 23(1):12-7. PubMed ID: 10652851
    [No Abstract]   [Full Text] [Related]  

  • 44. Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease.
    Roos CJ; Quax PH; Jukema JW
    Biomark Med; 2012 Feb; 6(1):35-52. PubMed ID: 22296195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidant stress and skeletal muscle microvasculopathy in the metabolic syndrome.
    Goodwill AG; Frisbee JC
    Vascul Pharmacol; 2012; 57(5-6):150-9. PubMed ID: 22796585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidative stress in heart failure: what are we missing?
    Sawyer DB
    Am J Med Sci; 2011 Aug; 342(2):120-4. PubMed ID: 21747279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Abnormalities of magnesium (Mg) metabolism and therapeutic significance of Mg administration in patients with metabolic syndrome, type 2 diabetes, heart failure and chronic hemodialysis].
    Kikuchi K; Tanaka H; Gima M; Kashiwagi Y; Shida H; Kawamura Y; Hasebe N
    Clin Calcium; 2012 Aug; 22(8):1217-26. PubMed ID: 22846358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin resistance and heart failure.
    Heck PM; Dutka DP
    Curr Heart Fail Rep; 2009 Jun; 6(2):89-94. PubMed ID: 19486592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxygen and perinatal origins of adulthood diseases: is oxidative stress the unifying element?
    Davidge ST; Morton JS; Rueda-Clausen CF
    Hypertension; 2008 Nov; 52(5):808-10. PubMed ID: 18852382
    [No Abstract]   [Full Text] [Related]  

  • 50. Strategies of Unloading the Failing Heart from Metabolic Stress.
    Koutroumpakis E; Jozwik B; Aguilar D; Taegtmeyer H
    Am J Med; 2020 Mar; 133(3):290-296. PubMed ID: 31520618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.
    Hayden MR; Tyagi SC
    Cardiovasc Diabetol; 2002 Sep; 1():3. PubMed ID: 12392600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired Vascular Redox Signaling in the Vascular Complications of Obesity and Diabetes Mellitus.
    Akoumianakis I; Antoniades C
    Antioxid Redox Signal; 2019 Jan; 30(3):333-353. PubMed ID: 29084432
    [No Abstract]   [Full Text] [Related]  

  • 53. Commentary on the Article "Multiple Hormonal and Metabolic Deficiency Syndrome Predicts Outcome in Heart Failure: The T.O.S.CA. Registry", Antonio Cittadini
    Triggiani V; Lisco G
    Endocr Metab Immune Disord Drug Targets; 2022; 22(6):545-548. PubMed ID: 34911431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A study of the content of incompletely oxidized organic substances in exhaled air].
    Nikberg II
    Klin Med (Mosk); 1967 May; 45(5):70-2. PubMed ID: 4885878
    [No Abstract]   [Full Text] [Related]  

  • 55. Evidence for enhanced oxidative stress in coronary heart disease and chronic heart failure.
    Wolfram R; Oguogho A; Palumbo B; Sinzinger H
    Adv Exp Med Biol; 2003; 525():197-200. PubMed ID: 12751767
    [No Abstract]   [Full Text] [Related]  

  • 56. The cardio-renal-metabolic connection: a review of the evidence.
    Marassi M; Fadini GP
    Cardiovasc Diabetol; 2023 Jul; 22(1):195. PubMed ID: 37525273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heart Failure and Diabetes Mellitus: Dangerous Liaisons.
    Lee HY
    Int J Heart Fail; 2022 Oct; 4(4):163-174. PubMed ID: 36381018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy.
    El-Azab MF; Wakiel AE; Nafea YK; Youssef ME
    World J Diabetes; 2022 May; 13(5):387-407. PubMed ID: 35664549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence.
    Palazzuoli A; Iacoviello M
    Heart Fail Rev; 2023 May; 28(3):585-596. PubMed ID: 35522391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Type 2 Diabetes Mellitus Increases The Risk of Late-Onset Alzheimer's Disease: Ultrastructural Remodeling of the Neurovascular Unit and Diabetic Gliopathy.
    Hayden MR
    Brain Sci; 2019 Sep; 9(10):. PubMed ID: 31569571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.